Therapeutic modulation of aortic stiffness

American Journal of Therapeutics

Volumn 23, Issue 6, 2016, Pages e1644-e1653

  Hussein, Ahmed Muzhir ^a   Shaaya, Ghazwan ^a   Arora, Rohit ^b   Al Khazaali, Ali ^b,c   Al Khafaji, Khalid ^b,c   Helu, Hanan K ^d  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Internal Medicine Residency   (United States)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d NORTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

Aortic stiffness; Pulse wave velocity

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINERALOCORTICOID ANTAGONIST; ORAL ANTIDIABETIC AGENT; RENIN INHIBITOR; VITAMIN D; ANTIDIABETIC AGENT; ENDOTHELIN A RECEPTOR;

AEROBIC EXERCISE; ARTERIAL STIFFNESS; ARTICLE; BODY WEIGHT; DIET; HUMAN; MUSIC THERAPY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WEIGHT REDUCTION; AGONISTS; AORTIC DISEASES; DRUG EFFECTS; EXERCISE; PHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; AORTIC DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIET; EXERCISE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOGLYCEMIC AGENTS; RECEPTOR, ENDOTHELIN A; VASCULAR STIFFNESS; VITAMIN D; WEIGHT LOSS;

EID: 84978536279     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0000000000000408     Document Type: Article

References (88)

1. Vlachopoulos C, Alexopoulos N, Stefanadis C. Aortic stiffness: prime time for integration into clinical practice. Hellenic J Cardiol. 2010;51:385-390.
2. Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875-881.
3. Vlachopoulos C, Aznaouridis K, Stefanadis C. Aortic stiffness for cardiovascular risk prediction: just measure it, just do it. J Am Coll Cardiol. 2014;63:647-649.
4. Brunner EJ, Shipley MJ, Witte DR, et al. Arterial stiffness, physical function, and functional limitation: the Whitehall II Study. Hypertension. 2011;57:1003-1009.
5. Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a Scientific Statement from the American heart association. Hypertension. 2015;66: 698-722.
6. Cavalcante JL, Lima JA, Redheuil A, et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57:1511-1522.
7. Johansen NB, Vistisen D, Brunner EJ, et al. Determinants of aortic stiffness: 16-year follow-up of the Whitehall II study. PLoS One. 2012;7:e37165.
8. Petersen KS, Blanch N, Keogh JB, et al. Effect of weight loss on pulse wave velocity: systematic review and metaanalysis. Arterioscler Thromb Vasc Biol. 2015;35:243-252.
9. Cooper JN, Buchanich JM, Youk A, et al. Reductions in arterial stiffness with weight loss in overweight and obese young adults: potential mechanisms. Atherosclerosis. 2012;223:485-490.
10. Hughes TM, Althouse AD, Niemczyk NA, et al. Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial. Cardiovasc Diabetol. 2012;11:114.
11. Liu AH, Bondonno CP, Croft KD, et al. Effects of a nitrate-rich meal on arterial stiffness and blood pressure in healthy volunteers. Nitric Oxide. 2013;35:123-130.
12. Habauzit V, Verny MA, Milenkovic D, et al. Flavanones protect from arterial stiffness in postmenopausal women consuming grapefruit juice for 6 mo: a randomized, controlled, crossover trial. Am J Clin Nutr. 2015;102:66-74.
13. Johnson SA, Figueroa A, Navaei N, et al. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with preand stage 1-hypertension: a randomized, doubleblind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015;115:369-377.
14. Pase MP, Grima NA, Sarris J. The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am J Clin Nutr. 2011;93:446-454.
15. Li CH, Yang YC, Wu JS, et al. Increased tea consumption is associated with decreased arterial stiffness in a Chinese population. PLoS One. 2014;9:e86022. eCollection 2014.
16. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932-943.
17. Edwards DG, Farquhar WB. Vascular effects of dietary salt. Curr Opin Nephrol Hypertens. 2015;24:8-13.
18. Jablonski KL, Fedorova OV, Racine ML, et al. Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness. Clin J Am Soc Nephrol. 2013;8:1952-1959.
19. Sasaki S, Yoshioka E, Saijo Y, et al. Relation between alcohol consumption and arterial stiffness: a crosssectional study of middle-aged Japanese women and men. Alcohol. 2013;47:643-649.
20. Endes S, Schaffner E, Caviezel S, et al. Physical activity is associated with lower arterial stiffness in older adults: results of the SAPALDiA 3 Cohort Study. Eur J Epidemiol. 2016;31:275-285.
21. Montero D, Roche E, Martinez-Rodriguez A. The impact of aerobic exercise training on arterial stiffness in preand hypertensive subjects: a systematic review and meta-analysis. Int J Cardiol. 2014;173:361-368.
22. Vlachopoulos C, Aggelakas A, Ioakeimidis N, et al. Music decreases aortic stiffness and wave reflections. Atherosclerosis. 2015;240:184-189.
23. Jones A, Vennelle M, Connell M, et al. The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized controlled trial in patients without cardiovascular disease. Sleep Med. 2013;14: 1260-1265.
24. Vlachantoni IT, Dikaiakou E, Antonopoulos CN, et al. Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev. 2013;17:19-28.
25. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162:2166-2171.
26. Phillips CL, Yee B, Yang Q, et al. Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP. Chest. 2008;134:94-100.
27. Kartali N, Daskalopoulou E, Geleris P, et al. The effect of continuous positive airway pressure therapy on blood pressure and arterial stiffness in hypertensive patients with obstructive sleep apnea. Sleep Breath. 2014;18:635-640.
28. Buchner NJ, Quack I, Stegbauer J, et al. Treatment of obstructive sleep apnea reduces arterial stiffness. Sleep Breath. 2012;16:123-133.
29. Janic M, Lunder M, Sabovic M. Arterial stiffness and cardiovascular therapy. Biomed Res Int. 2014;2014:621437.
30. Koumaras C, Tziomalos K, Stavrinou E, et al. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens. 2014;8:74-82.
31. Ripley DP, Negrou K, Oliver JJ, et al. Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study. Clin Exp Hypertens. 2015;37:308-316.
32. Dudenbostel T, Glasser SP. Effects of antihypertensive drugs on arterial stiffness. Cardiol Rev. 2012;20:259-263.
33. Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012;221:18-33.
34. Mitchell GF, Dunlap ME, Warnica W, et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensinconverting enzyme inhibition hemodynamic substudy. Hypertension. 2007;49:1271-1277.
35. Andreadis EA, Angelopoulos ET, Kolyvas GN, et al. The effect of aliskiren versus ramipril-based treatment on the Ambulatory Arterial Stiffness Index in hypertensive patients. Int Angiol. 2014;33:78-83.
36. Mediavilla García JD, Fernández-Torres C, Jaen Aguila F, et al. Effect of olmesartan medoxomil on arterial stiffness in patients with essential hypertension. Med Clin (Barc). 2007;128:726-729.
37. Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens. 2002;15(4 pt 1): 321-325.
38. Ghiadoni L, Virdis A, Magagna A, et al. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension. 2000;35(1 pt 2):501-506.
39. Frimodt-Møller M, Kamper AL, Strandgaard S, et al. Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease-a randomized trial. PLoS One. 2012;7:e41757.
40. Hayoz D, Zappe DH, Meyer MA, et al. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen. J Clin Hypertens (Greenwich). 2012;14:773-778.
41. Asmar R. Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and type 2 diabetes mellitus. J Renin Angiotensin Aldosterone Syst. 2001;2(suppl 2):S8-S11.
42. Karalliedde J, Smith A, DeAngelis L, et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension. 2008;51:1617-1623.
43. Guo JQ, Wang HY, Sun NL. Effect of aliskiren on arterial stiffness, compared with ramipril in patients with mild to moderate essential hypertension. Chin Med J (Engl). 2013; 126:1242-1246.
44. Cherney DZ, Lai V, Scholey JW, et al. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care. 2010;33:361-365.
45. Edwards NC, Steeds RP, Stewart PM, et al. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol. 2009;54:505-512.
46. Vizzardi E, Pina PD, Caretta G, et al. The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown). 2015;16:597-602.
47. Shibata T, Tsutsumi J, Hasegawa J, et al. Effects of addon therapy consisting of a selective mineralocorticoid receptor blocker on arterial stiffness in patients with uncontrolled hypertension. Intern Med. 2015;54:1583-1589.
48. Savoia C, Touyz RM, Amiri F, et al. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension. 2008;51:432-439.
49. Boutouyrie P, Beaussier H, Achouba A, et al. Destiffening effect of valsartan and atenolol: influence of heart rate and blood pressure. J Hypertens. 2014;32:108-114.
50. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens. 2008;21:663-667.
51. Agabiti-Rosei E, Porteri E, Rizzoni D. Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag. 2009;5:353-360.
52. Polónia J, Barbosa L, Silva JA, et al. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with b-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Blood Press Monit. 2010;15:235-239.
53. Komai N, Ohishi M, Moriguchi A, et al. Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation. Hypertens Res. 2002;25:5-10.
54. Wykretowicz A, Guzik P, Krauze T, et al. Add-on therapy with doxazosin in patients with hypertension influences arterial stiffness and albuterol-mediated arterial vasodilation. Br J Clin Pharmacol. 2007;64:792-795.
55. Alem M, Milia P, Muir S, et al. Comparison of the effects of diuretics on blood pressure and arterial stiffness in patients with stroke. J Stroke Cerebrovasc Dis. 2008;17: 373-377.
56. Duda-Seiman D, Duda-Seiman C, Borcan F, et al. Calcium channel blockers-benefits upon vascular biology in hypertensive patients. Cardiovasc Hematol Agents Med Chem. 2015;13:54-62.
57. Ihm SH, Jeon HK, Chae SC, et al. Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension. Chin Med J (Engl). 2013;126:2021-2028.
58. Matsui Y, Eguchi K, O'Rourke MF, et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009;54:716-723.
59. Geronikaki A, Gavalas A, Dislian V, et al. Inhibition of renin-angiotensin system and advanced glycation end products formation: a promising therapeutic approach targeting on cardiovascular diseases. Cardiovasc Hematol Agents Med Chem. 2007;5:249-264.
60. Steppan J, Tran H, Benjo AM, et al. Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness. Exp Gerontol. 2012;47: 565-572.
61. Oudegeest-Sander MH, Olde Rikkert MG, Smits P, et al. The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial. Exp Gerontol. 2013;48:1509-1517.
62. Mihos CG, Pineda AM, Santana O. Cardiovascular effects of statins, beyond lipid-lowering properties. Pharmacol Res. 2014;88:12-19.
63. Wang ZG, Chen BW, Lü NQ, et al. Relationships between use of statins and arterial stiffness in normotensive and hypertensive patients with coronary artery disease. Chin Med J (Engl). 2013;126:3087-3092.
64. Tousoulis D, Oikonomou E, Siasos G, et al. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure. Atherosclerosis. 2013;227: 367-372.
65. Kanaki AI, Sarafidis PA, Georgianos PI, et al. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. Am J Hypertens. 2013;26: 608-616.
66. Kontopoulos AG, Athyros VG, Pehlivanidis AN, et al. Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients. Curr Med Res Opin. 2003;19:22-27.
67. Harashima K, Hayashi J, Miwa T, et al. Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus. Metabolism. 2009;58:739-745.
68. Ohira M, Yamaguchi T, Saiki A, et al. Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin. Diabetes Metab Syndr Obes. 2014;7:313-319.
69. Marder W, Khalatbari S, Myles JD, et al. The peroxisome proliferator activated receptor-g pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis. J Am Heart Assoc. 2013; 2:e000441.
70. Agarwal N, Rice SP, Bolusani H, et al. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab. 2010;95:722-730.
71. Kaya MG, Calapkorur B, Karaca Z, et al. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77:885-892.
72. Mäki-Petäjä KM, Wilkinson IB. Anti-inflammatory drugs and statins for arterial stiffness reduction. Curr Pharm Des. 2009;15:290-303.
73. Zanoli L, Rastelli S, Inserra G, et al. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs. Atherosclerosis. 2014;234:346-351.
74. Mäki-Petäjä KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. 2006;114:1185-1192.
75. Angel K, Provan SA, Fagerhol MK, et al. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens. 2012;25:644-650.
76. Schillaci G, Bartoloni E, Pucci G, et al. Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment. Ann Rheum Dis. 2012;71:1151-1156.
77. Şeker T, GürM, Kuloglu O, et al. Serum 25-hydroxyVitamin D is associated with both arterial and ventricular stiffness in healthy subjects. J Cardiol. 2013;62:361-365.
78. Ashraf AP, Alvarez JA, Dudenbostel T, et al. Associations between vascular health indices and serum total, free and bioavailable 25-hydroxyVitamin D in adolescents. PLoS One. 2014;9:e114689.
79. McGreevy C, Barry M, Davenport C, et al. The effect of Vitamin D supplementation on arterial stiffness in an elderly community-based population. J Am Soc Hyperten. 2015;9:176-183.
80. Reynolds JA, Haque S, Berry JL, et al. 25-HydroxyVitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012;51:544-551.
81. Breslavsky A, Frand J, Matas Z, et al. Effect of high doses of Vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr. 2013;32:970-975.
82. Ashor AW, Siervo M, Lara J, et al. Antioxidant vitamin supplementation reduces arterial stiffness in adults: a systematic review and meta-analysis of randomized controlled trials. J Nutr. 2014;144:1594-1602.
83. Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007;20:392-397.
84. Zureik M, Galan P, Bertrais S, et al. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol. 2004;24:1485-1491.
85. Nar G, Soylu K, Akcay M, et al. Evaluation of the relationship between arterial blood pressure, aortic stiffness and serum endothelin-1 levels in patients with essential hypertension. Clin Exp Hypertens. 2013;35:589-594.
86. Dhaun N, Melville V, Blackwell S, et al. Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD. J Am Soc Nephrol. 2013;24:31-36.
87. Dhaun N, Macintyre IM, Melville V, et al. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension. 2009;54: 113-119.
88. Dhaun N, MacIntyre IM, Kerr D, et al. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease. Hypertension. 2011;57:772-779.